Dosidal · Switzerland

Pamorelin LA 3.75 mg, poudre et solvant pour suspension injectable à libération prolongée

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:52815 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 52815
atc: L02AE04
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 1998-01-14
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L02AE04
authorisation_number: 52815
form: PULMS
holder: Debiopharm Research & Manufacturing SA
holder_partner_nr: 1006677
it_number: 07.16.2.
name: Pamorelin LA 3.75 mg, poudre et solvant pour suspension injectable à libération prolongée
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
TAs3Dc_GQ--_9A_1U_pGoVUf0GXBgjppCsaw1oP5rKy0inXbaj1M-nw61XPhUcoA6n3CFbzuYx6UJYhjzy1yzw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal